In the case of EMD Millipore Corporation vs Assistant Controller of Patents and Designs, the Delhi High Court held that a non-invasive method for analysing biomolecules is not…
Dr. Kalyan Kankanala · 3 Nov 2025
Delhi HC rules Sequenom’s NIPT methods are excluded as “diagnostic” under Section 3(i) and hit by 3(b) for sex selection concerns, while keeping the door open for tools…
Neetha Mohan · 28 Oct 2025
The Delhi High Court dismissed Roche’s appeal against Natco Pharma, finding the Risdiplam patent prima facie obvious due to its similarity with prior genus patents, paving the way…
Neetha Mohan · 17 Oct 2025
In Base SE v. Deputy Controller of Patents, the Calcutta High Court ruled that scientific and technical inventions addressing agricultural problems are not excluded under Section 3(h). It…
Anjali Santhosh · 14 Oct 2025
Delhi HC upholds Saint-Gobain patent rejection, ruling that the glass coating claim lacked inventive step and failed to show technical advancement.
Sowmya S Murthy · 10 Oct 2025
Delhi HC affirms rejection of a patent on ZLD process from distillery waste, citing lack of inventive step and application of Section 3(d) of the Patents Act.
Gaurav Mishra · 9 Oct 2025
Delhi HC sets aside patent rejection for IV catheter, citing flawed inventive step analysis under Agriboard test and lack of reasoned decision.
Gaurav Mishra · 3 Oct 2025
In the case of Helsinn Healthcare SA vs AET Laboratories, the Delhi High Court declined to entertain a patent infringement action filed in anticipation of future infringement. The…
Dr. Kalyan Kankanala · 1 Oct 2025
The Delhi High Court dismissed Novartis’s writ petitions, ruling it had waived cross-examination by opting for rebuttal evidence. The Controller’s orders were upheld, with the patent already revoked…
Neetha Mohan · 23 Sep 2025
Madras HC upholds CRI patentability in Syngene’s case, ruling novel hardware isn’t a prerequisite for protection under Section 3(k).
Sowmya S Murthy · 19 Sep 2025